Gut microbiota in Parkinson disease in a northern German cohort
GLP-1 drugs might also promote weight loss by reducing the amount of visceral fat the type of fat that surrounds organs and can contribute to conditions like obesity , fatty liver disease, and diabetes
While Levodopa remains the gold standard, its limitations necessitate combination therapy and adjunct modalities such as deep brain stimulation and nanocarrier-based drug delivery
SURMOUNT-1 data show meaningful weight loss at all three maintenance dose tiers: approximately 15% at 5 mg, 19.5% at 10 mg, and 20.9% at 15 mg
While Ozempic (semaglutide) and Adderall (amphetamine/dextroamphetamine) arent FDA-approved weight loss drugs, healthcare providers sometimes prescribe these medications off-label to help with weight management
Created with clinically researched ingredients backed by science and trusted by health professionals